NYSE:LH

Laboratory Co. of America Earnings Date, Estimates, & History

$242.45

-5.30 (-2.14%)

(As of 05/18/2022 04:00 PM ET)

Add

Compare

Today's Range: $241.47
▼
$248.09
50-Day Range: $238.59
▼
$277.87
52-Week Range: $232.01
▼
$317.17

Volume: 506,534 shs
Average Volume: 883,893 shs
Market Capitalization: $22.48 billion

P/E Ratio: 11.13
Dividend Yield: N/A
Beta: 1.04

Upcoming Earnings Date: Aug. 4Estimated
Actual EPS (Apr. 28): $6.11 Beat By $0.23
Consensus EPS (Apr. 28): $5.88
Last Year's Q2 EPS (4/28/2021): $8.79

Read Call Transcript

Listen to Call

Latest SEC 10-Q Filing

Earnings Per Share Revenue

Laboratory Co. of America Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Laboratory Co. of America Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Laboratory Co. of America (NYSE:LH) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2022	4	$4.46	$6.36	$5.30
Q2 2022	5	$4.36	$5.50	$4.79
Q3 2022	5	$4.20	$4.82	$4.57
Q4 2022	5	$4.16	$4.42	$4.31
FY 2022	19	$17.18	$21.10	$18.96
Q1 2023	1	$4.19	$4.19	$4.19
Q2 2023	1	$4.58	$4.58	$4.58
Q3 2023	1	$5.01	$5.01	$5.01
Q4 2023	1	$4.59	$4.59	$4.59
FY 2023	4	$18.37	$18.37		$18.37

LH Earnings Information

Laboratory Co. of America last released its quarterly earnings data on April 28th, 2022. The medical research company reported $6.11 EPS for the quarter, beating analysts' consensus estimates of $5.88 by $0.23. The business had revenue of $3.90 billion for the quarter, compared to the consensus estimate of $4.01 billion. Its revenue for the quarter was down 7.1% on a year-over-year basis. Laboratory Co. of America has generated $21.79 earnings per share over the last year ($21.79 diluted earnings per share) and currently has a price-to-earnings ratio of 11.1. Earnings for Laboratory Co. of America are expected to decrease by -9.25% in the coming year, from $19.90 to $18.06 per share. Laboratory Co. of America has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off prior year's report dates.

Laboratory Co. of America (NYSE:LH) Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/4/2022 (Estimated)
4/28/2022	Q1 2022	$5.88	$6.11	+$0.23	$6.99	$4.01 billion	$3.90 billion
2/10/2022	Q4 2021	$5.90	$6.77	+$0.87	$7.79	$3.93 billion	$4.06 billion
10/27/2021	9/30/2021	$4.92	$6.82	+$1.90	$7.59	$3.63 billion	$4.06 billion
7/28/2021	6/30/2021	$5.64	$6.13	+$0.49	$7.50	$3.59 billion	$3.84 billion
4/28/2021	3/31/2021	$7.32	$8.79	+$1.47	$9.76	$3.88 billion	$4.16 billion
2/10/2021	12/31/2020	$8.11	$10.56	+$2.45	$11.58	$3.98 billion	$4.49 billion
11/1/2020	9/30/2020	$5.31	$8.41	+$3.10	$9.65	$3.62 billion	$3.90 billion
7/28/2020	6/30/2020	$0.78	$2.57	+$1.79	$2.77	$2.44 billion	$2.77 billion
4/29/2020	3/31/2020	$1.95	$2.37	+$0.42	$8.01	$2.73 billion	$2.82 billion
2/13/2020	Q4 2019	$2.80	$2.86	+$0.06	$3.40	$2.92 billion	$3.00 billion

10/24/2019	Q3 19	$2.85	$2.90	+$0.05	$3.55	$2.91 billion	$2.93 billion
7/25/2019	Q2	$2.90	$2.93	+$0.03	$3.93	$2.89 billion	$2.88 billion
4/30/2019	3/31/2019	$2.53	$2.62	+$0.09	$3.38	$2.82 billion	$2.79 billion
2/7/2019	12/31/2018	$2.48	$2.52	+$0.04	$3.48	$2.78 billion	$2.79 billion
10/24/2018	9/30/2018	$2.88	$2.74	($0.14)	$2.38	$2.84 billion	$2.83 billion
7/25/2018	Q2 2018	$2.92	$2.98	+$0.06	$3.69	$2.85 billion	$2.87 billion
4/25/2018	Q1 2018	$2.63	$2.78	+$0.15	$3.89	$2.77 billion	$2.85 billion
2/6/2018	Q4 2017	$2.38	$2.45	+$0.07	($1.91)	$2.70 billion	$2.70 billion
10/25/2017	Q3 2017	$2.38	$2.46	+$0.08	$3.18	$2.55 billion	$2.60 billion
7/26/2017	Q2 2017	$2.40	$2.47	+$0.07	$3.12	$2.47 billion	$2.50 billion
4/25/2017	Q1 2017	$2.19	$2.22	+$0.03	$2.60	$2.41 billion	$2.41 billion
2/16/2017	Q416	$2.13	$2.15	+$0.02	$2.55	$2.35 billion	$2.39 billion
10/26/2016	Q316	$2.29	$2.25	($0.04)	$2.79	$2.38 billion	$2.40 billion
7/27/2016	Q216	$2.30	$2.31	+$0.01	$2.71	$2.33 billion	$2.40 billion
4/25/2016	Q116	$1.96	$2.02	+$0.06	$2.49	$2.19 billion	$2.30 billion
2/18/2016	Q415	$1.99	$1.98	($0.01)	$2.85	$2.22 billion	$2.24 billion
10/26/2015	Q315	$2.07	$2.07		$2.65	$2.25 billion	$2.30 billion
7/28/2015	Q215	$2.03	$2.09	+$0.06	$2.54	$2.22 billion	$2.20 billion
4/27/2015	Q115	$1.63	$1.73	+$0.10	$3.45	$1.79 billion	$1.80 billion
2/20/2015	Q4	$1.63	$1.65	+$0.02	$1.91	$1.49 billion	$1.51 billion
10/28/2014	Q3	$1.75	$1.80	+$0.05	$2.01	$1.56 billion	$1.55 billion
7/18/2014	Q214	$1.77	$1.84	+$0.07	$2.04	$1.50 billion	$1.52 billion
4/28/2014	Q114	$1.58	$1.51	($0.07)	$1.71	$1.45 billion	$1.43 billion
2/7/2014	Q4 2013	$1.67	$1.61	($0.06)	$1.79	$1.46 billion	$1.44 billion
10/18/2013	Q3 2013	$1.79	$1.80	+$0.01	$1.97	$1.45 billion	$1.46 billion
7/19/2013	Q2 2013	$1.78	$1.80	+$0.02	$1.98	$1.46 billion	$1.47 billion
4/19/2013	Q1 2013	$1.77	$1.74	($0.03)	$1.92	$1.45 billion	$1.44 billion
2/8/2013	Q4 2012	$1.62	$1.54	($0.08)		$1.39 billion	$1.41 billion
10/18/2012		$1.74	$1.76	+$0.02
7/19/2012		$1.76	$1.77	+$0.01
4/19/2012		$1.67	$1.74	+$0.07
2/10/2012		$1.41	$1.46	+$0.05
10/20/2011		$1.50	$1.61	+$0.11
7/21/2011		$1.53	$1.64	+$0.11
4/21/2011		$1.46	$1.52	+$0.06
2/10/2011		$1.31	$1.34	+$0.03
10/21/2010	Q3 2010	$1.40	$1.47	+$0.07	$1.60
7/22/2010	Q2 2010	$1.42	$1.46	+$0.04	$1.46
4/21/2010	Q1 2010	$1.31	$1.30	($0.01)	$1.35
2/11/2010	Q4 2009	$1.15	$1.16	+$0.01	$0.99
10/22/2009	Q3 2009	$1.15	$1.22	+$0.07	$1.23
7/23/2009	Q2 2009	$1.27	$1.30	+$0.03	$1.36
4/23/2009	Q1 2009	$1.17	$1.22	+$0.05	$1.22
2/12/2009	Q4 2008	$1.09	$1.10	+$0.01	$1.12
10/23/2008	Q3 2008	$1.12	$1.13	+$0.01	$1.26
7/24/2008	Q2 2008	$1.24	$1.24		$1.56
4/24/2008	Q1 2008	$1.14	$1.14		$1.14
2/7/2008	Q4 2007	$1.00	$1.04	+$0.04	$1.10

(Earnings results data provided by Zacks Investment Research)

Laboratory Co. of America (NYSE:LH) Earnings Frequently Asked Questions

When is Laboratory Co. of America's earnings date?: Laboratory Co. of America has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off last year's report dates. Learn more on LH's earnings history.
Did Laboratory Co. of America beat their earnings estimates last quarter?: In the previous quarter, Laboratory Co. of America (NYSE:LH) reported $6.11 earnings per share (EPS) to beat the analysts' consensus estimate of $5.88 by $0.23. Learn more on analysts' earnings estimate vs. LH's actual earnings.
How can I listen to Laboratory Co. of America's earnings conference call?: The conference call for Laboratory Co. of America's latest earnings report can be listened to online. Listen to Conference Call
How can I read Laboratory Co. of America's conference call transcript?: The conference call transcript for Laboratory Co. of America's latest earnings report can be read online. Read Transcript
How can I view Laboratory Co. of America's earnings report?: Laboratory Co. of America's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Laboratory Co. of America generate each year?: Laboratory Co. of America (NYSE:LH) has a recorded annual revenue of $16.12 billion.
How much profit does Laboratory Co. of America generate each year?: Laboratory Co. of America (NYSE:LH) has a recorded net income of $2.38 billion. LH has generated $21.79 earnings per share over the last four quarters.
What is Laboratory Co. of America's price-to-earnings ratio?: Laboratory Co. of America (NYSE:LH) has a trailing price-to-earnings ratio of 11.13 and a forward price-to-earnings ratio of 12.18.
What is Laboratory Co. of America's EPS forecast for next year?: Laboratory Co. of America's earnings are expected to decrease from $19.90 per share to $18.06 per share in the next year, which is a -9.25% change.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources